Sarepta Therapeutics ( NASDAQ:SRPT – Get Rating ) released its quarterly earnings results on Tuesday. The biotechnology company reported ($0.97) earnings per share for the quarter, topping the consensus estimate of ($1.58) by $0.61, Briefing.com reports. The business had revenue of $253.50 million for the quarter, compared to analysts' expectations of $241.47 million. Sarepta Therapeutics had a negative net margin of 75.40% and a negative return on equity of 117.29%. The firm's revenue for the quarter was up 20.

https://www.dailypolitical.com/2023/05/02/sarepta-therapeutics-nasdaqsrpt-posts-earnings-results-beats-expectations-by-0-61-eps.html

#dailypolitical